pharma · Unresectable Hepatocellular Carcinoma (HCC) · Unexplained Recurrent Miscarriage and Recurrent Implantation Failure
Zenshine Pharmaceuticals
Nanjing Zenshine Pharmaceuticals
Nanjing Zenshine Pharmaceuticals is a pharma organization headquartered in CN. Primary therapeutic focus areas include Unresectable Hepatocellular Carcinoma (HCC), Unexplained Recurrent Miscarriage and Recurrent Implanta
Company details
- Status
- Public
- HQ
- CN
- Founded
- 2018
- Employees
- 12
- Programs
- 8
- Drugs
- 17
- Patents
- 0
low-dose lymphocyte immunotherapy
Phase 2 · other · Unexplained Recurrent Miscarriage and Recurrent Implantation Failure
low-dose lymphocyte immunotherapy for Unexplained Recurrent Miscarriage and Recurrent Implantation Failure is a Phase 2 program (other) at Nanjing Zenshine Pharmaceuticals with 1 ClinicalTrials.gov record(s).
Internal code BL2015007
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Nanjing Zenshine Pharmaceuticals
- Phase
- Phase 2
- Modality
- other
- Indication
- Unexplained Recurrent Miscarriage and Recurrent Implantation Failure
- Status
- completed
- Trials
- 1